ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Rewriting the Book on Infectious Disease

by John Austin • July 1, 2006

  • Tweet
  • Email
Print-Friendly Version

Chicago—West Nile Virus, SARS, Lyme disease, HIV—these aren’t our parents’ infectious diseases anymore. When it comes to diagnosing the often misleading manifestations and defining the puzzling pathways behind these and many other diseases, today’s physician must be part scientist, part sleuth.

You Might Also Like

  • Nasal Spray of Engineered Proteins Provides Protection Against H1N1 in Mice
  • Tonsillectomy, Adenoidectomy Tied to Higher Risks of Respiratory, Allergic, Infectious Diseases
  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Pediatric Extraesophageal Reflux Disease: A Diagnostic Dilemma
Explore This Issue
July 2006

“When we think in terms of traditional infections, we like to think of effects that are manifested at the site of the infection, such as polio virus where you have paralysis, or infections of the intestinal tract where you have symptoms like diarrhea,” said W. Ian Lipkin, MD. “In recent years, though, new paradigms are emerging… and there are much more complicated mechanisms to consider.”

Dr. Lipkin discussed the significance of these new paradigms as the Triological Society‘s Presidential Speaker here at the 2006 Combined Otolaryngology Spring Meetings (COSM). Dr. Lipkin is the Greene Professor of Epidemiology and Professor of Neurology and Pathology at the Mailman School of Public Health and College of Physicians and Surgeons at Columbia University in New York City. He is also the director of the Jerome L. and Dawn Greene Infectious Disease Laboratory and principal investigator of the Northeast Biodefense Center.

Dr. Ian LipkinDr. Ian Lipkin delivered a talk on “Emerging Paradigms in Infectious Diseases” as the Presidential Speaker at the Triological Society portion of the Combined Otolaryngology Spring Meetings in Chicago.

Emerging Paradigms

In the late 1800s, the German physician Robert Koch, in an effort to demonstrate that tubercle bacillus was responsible for tuberculosis, defined the set of criteria that must be present in order to determine a causal relationship between a microbial agent and an infectious disease. Koch’s Postulates held that the microbe had to be present in every case of the disease; it had to be specific; and scientists had to be able to isolate it, grow it, and introduce it into animals to cause a similar disease. And, for the past century or so, that has all pretty much held true.

“In this new era of molecular microbiology, however, Koch’s Postulates don’t work,” Dr. Lipkin said. “We’re not entirely sure yet what the new postulates will be. But we do know that there are microbes that we can’t grow in the laboratory, that not everybody infected with the same agent has the same manifestations, and that the sequelae may be long term.”

Dr. Lipkin points to instances of disease where the infection itself is not the problem, but the immune response of the infected host and the resulting damage—such as a virus or bacterium that manifests in immunosuppression, which may predispose to a variety of other disorders.

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Medical Education, Pediatric, Practice Focus Tagged With: COSM, diagnosis, infection, patient safety, pediatricsIssue: July 2006

You Might Also Like:

  • Nasal Spray of Engineered Proteins Provides Protection Against H1N1 in Mice
  • Tonsillectomy, Adenoidectomy Tied to Higher Risks of Respiratory, Allergic, Infectious Diseases
  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Pediatric Extraesophageal Reflux Disease: A Diagnostic Dilemma

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.